OWC Pharmaceutical Research Corp. - Consolidated Balance Sheets		Jun. 30, 2016 USD ($)	Dec. 31, 2015 USD ($)
Current Assets:
Cash		$ 162,283	$ 357,161
Other receivables		7,699	11,797
Prepaid expenses		$ 49,035	$ 38,591
Total current assets		219,017	407,549
Property and equipment, net		$ 19,934	$ 22,899
Total assets		238,951	430,448
Current Liabilities:
Accounts payable - trade		$ 31,713	$ 28,125
Accrued expenses		24,418	24,607
Customer deposit		$ 150,000	$ 50,000
Advances and accounts payable to related parties		1,820	1,820
Derivatives		53,572	0
Current portion of convertible notes payable net of discount		51,969	3,074
Current portion of convertible note - default		37,500	0
Total current liabilities		350,992	107,626
Total liabilities		$ 350,992	$ 107,626
Stockholders' equity:
Preferred stock	[1]	0	0
Common stock	[2]	815	815
Additional paid-in capital		8,541,599	8,533,525
Common stock subscriptions receivable		$ (651,730)	$ (651,730)
Accumulated deficit		(8,036,984)	(7,548,866)
Accumulated other comprehensive income		(3,241)	(10,922)
Total stockholders' equity (deficit)		$ (149,541)	$ 322,822
Total liabilities and stockholders' equity		$ 201,451	$ 430,448

[1] $0.0001 par value. Authorized 20,000,000 shares: none issued and outstanding at June 30, 2016 and December 31, 2015

[2] $0.0001 par value. Authorized 500,000,000 shares: 81,460,875 shares issued and outstanding at June 30, 2016 and December 31, 2015